Experience of Patients Starting Hemodialysis

May 18, 2022 updated by: Satellite Healthcare

Experience of Patients Starting Hemodialysis: A Qualitative Study

Patients starting dialysis have significant and often daunting changes to their lifestyle, and investigators have only little information from the patient perspective on patient experiences during dialysis initiation. To explore patient perspectives when starting dialysis, this study aims to collect information on patient perspectives.

Study Overview

Status

Completed

Conditions

Detailed Description

Patients starting dialysis have significant and often daunting changes to their lifestyle, and investigators have only little information from the patient perspective on patient experiences during dialysis initiation. To explore patient perspectives when starting dialysis, this study aims to collect information on patient perspectives, understand what made patient experiences better, and what could further improve their experiences when patients first start dialysis. The investigators will enroll patients within 90 days of starting dialysis, and conduct semi-structured recorded interviews with patients. All patients will provide informed consent. The interviews will be transcribed verbatim.

  • The transcripts will be reviewed line by line by qualitative researchers to identify concepts and themes, and will be developed into a coding schema.
  • The preliminary themes will be discussed among the investigators to facilitate consensus.

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Los Gatos, California, United States, 95032
        • Satellite Healthcare Los Gatos
      • Menlo Park, California, United States, 94025
        • Satellite Healthcare Menlo Park
      • Milpitas, California, United States, 95035
        • Satellite Heathcare Milpitas
      • Morgan Hill, California, United States, 95037
        • Satellite Dialysis Morgan Hill
      • Morgan Hill, California, United States, 95037
        • Satellite Health Morgan Hill
      • Mountain View, California, United States, 94040
        • Satellite Healthcare Mountain View
      • Oakland, California, United States, 94609
        • Satellite Healthcare Oakland
      • San Carlos, California, United States, 94070
        • Satellite Healthcare San Carlos
      • San Jose, California, United States, 95116
        • Satellite Healthcare East San Jose
      • San Jose, California, United States, 95118
        • Satellite Health Blossom Valley
      • San Jose, California, United States, 95119
        • Satellite Health San Teresa
      • San Jose, California, United States, 95121
        • Satellite Healthcare SIlver Creek
      • San Jose, California, United States, 95123
        • Satellite Health South San Jose
      • San Jose, California, United States, 95148
        • Satellite Healthcare Evergreen
      • San Leandro, California, United States, 94577
        • Satellite Dialysis San Leandro
      • San Leandro, California, United States, 94577
        • Satellite Healthcare West San Leandro
      • San Mateo, California, United States, 94403
        • Satellite Dialysis San Mateo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All incident in-center hemodialysis patients meeting eligibility criteria at Satellite Healthcare, Inc., at IRB approved dialysis centers.

Description

Inclusion Criteria:

  • Patients receiving in-center hemodialysis care at Satellite Healthcare at the start of the study period.
  • Patients who started with in-center hemodialysis as a first renal replacement therapy.
  • Patients receiving dialysis for ≤ 90 days.

Exclusion Criteria:

  • Age < 18 years.
  • Unable to understand or communicate in English.
  • Inability to participate because of cognitive impairment or active psychological condition.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Experiences of patients starting dialysis.
Time Frame: One time interview.
Collect information from interviews to understand the experiences of patients starting dialysis.
One time interview.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 2, 2021

Primary Completion (Actual)

March 31, 2022

Study Completion (Actual)

March 31, 2022

Study Registration Dates

First Submitted

July 26, 2021

First Submitted That Met QC Criteria

July 26, 2021

First Posted (Actual)

August 3, 2021

Study Record Updates

Last Update Posted (Actual)

May 20, 2022

Last Update Submitted That Met QC Criteria

May 18, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • SIH130

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No individual person data will be available to anyone other than Satellite Healthcare Research employees.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ESRD

Clinical Trials on None. This is a qualitative interview study.

3
Subscribe